We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$18.8B
AUM Growth
+$5.48B
Cap. Flow
+$4.71B
Cap. Flow %
24.99%
Top 10 Hldgs %
51.86%
Holding
224
New
70
Increased
30
Reduced
44
Closed
59

Sector Composition

Rank Sector Weight
1 Healthcare 10.89%
2 Technology 7.04%
3 Communication Services 6.72%
4 Energy 3.77%
5 Industrials 3.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAP icon
126
PUT
Molson Coors Class B
TAP
$7.93B
$3.49M 0.02%
50,000
AVOL
127
DELISTED
AVOLON HLDGS LTD SHS (CYM)
AVOL
$3.38M 0.02%
147,386
-232,614
-61% -$5.31M
TOWR
128
DELISTED
Tower International, Inc.
TOWR
$3.33M 0.02%
128,000
-6,000
-4% -$164K
AGN
129
DELISTED
Allergan plc
AGN
$3.23M 0.02%
10,647
-1,800
-14% -$537K
ANF icon
130
CALL
Abercrombie & Fitch
ANF
$4.9B
$3.01M 0.02%
140,000
VZ icon
131
CALL
Verizon
VZ
$195B
$2.91M 0.02%
62,400
-676,000
-92% -$33.1M
RYZ
132
Ryerson Holding Corp
RYZ
$1.4B
$2.73M 0.01%
300,000
-50,000
-14% -$379K
AAL icon
133
CALL
American Airlines Group
AAL
$11B
$2.4M 0.01%
60,000
-150,000
-71% -$6.84M
AER icon
134
AerCap
AER
$24.4B
$2.29M 0.01%
+50,000
New +$2.37M
FRM
135
DELISTED
FURMANITE CORPORATION COM
FRM
$2.27M 0.01%
+280,000
New +$2.3M
S
136
CALL
DELISTED
Sprint Corporation
S
$2.24M 0.01%
491,200
-208,800
-30% -$1M
AAPL icon
137
Apple
AAPL
$4.52T
$2.11M 0.01%
+67,200
New +$2.15M
FOMX
138
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$2.04M 0.01%
199,132
-480,868
-71% -$5.31M
SNCR
139
DELISTED
Synchronoss Technologies
SNCR
$1.83M 0.01%
+4,439
New +$1.91M
COLL icon
140
Collegium Pharmaceutical
COLL
$1.16B
$1.78M 0.01%
+100,000
New +$1.73M
KALV
141
DELISTED
KalVista Pharmaceuticals
KALV
$1.61M 0.01%
+16,071
New +$1.59M
ALPN
142
DELISTED
Alpine Immune Sciences Inc
ALPN
$1.51M 0.01%
+25,000
New +$1.49M
HRI icon
143
PUT
Herc Holdings
HRI
$5.71B
$1.45M 0.01%
26,667
BAC icon
144
Bank of America
BAC
$440B
$1.4M 0.01%
82,500
-82,500
-50% -$1.36M
CSTM icon
145
Constellium
CSTM
$4.02B
$1.35M 0.01%
114,570
-45,430
-28% -$714K
PPO
146
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
$1.2M 0.01%
20,000
CLVS
147
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$1.03M 0.01%
+11,700
New +$1M
GTI
148
DELISTED
GRAFTECH INTERNATIONAL LTD
GTI
$670K ﹤0.01%
+135,000
New +$639K
IVTY
149
DELISTED
Invuity, Inc
IVTY
$666K ﹤0.01%
+47,195
New +$686K
NMIH icon
150
NMI Holdings
NMIH
$3.34B
$401K ﹤0.01%
50,000

Similar funds

Pentwater Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Pentwater Capital Management held 224 positions worth $18.8B, up 41% from $13.4B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pentwater Capital Management deployed $4.71B of net new capital in Q2 2015, opening 70 new positions and adding to 30 existing holdings. Its largest new stake was BROADCOM CORP CL-A: 20,613,975 shares worth $1.06B.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 5.4% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Turquoise Hill Resources Ltd, an estimated $76.2M trimmed.

  • Pentwater Capital Management's largest Q2 2015 buy was BROADCOM CORP CL-A: 20,613,975 shares worth $1.06B.
  • Pentwater Capital Management added most to Altera Corp in Q2 2015, an estimated $456M increase.
  • Pentwater Capital Management's biggest Q2 2015 reduction was Turquoise Hill Resources Ltd, cutting an estimated $76.2M.
  • Pentwater Capital Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $652M.
  • Pentwater Capital Management's ten largest holdings make up 52% of its $18.8B portfolio in Q2 2015.
  • Pentwater Capital Management opened 70 new positions and closed 59 in Q2 2015.
  • Pentwater Capital Management's portfolio value rose 41% quarter-over-quarter to $18.8B.

Based on Pentwater Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.